Evolus Inc (EOLS)
13.04
+0.41
(+3.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.05
+0.01
(+0.08%)
After-Hours: 20:00
Evolus Debt to Equity Ratio: 20.58 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 20.58 |
| June 30, 2024 | 6.261 |
| March 31, 2024 | 6.541 |
| December 31, 2023 | -5.818 |
| September 30, 2023 | -4.910 |
| June 30, 2023 | -13.62 |
| March 31, 2023 | 10.37 |
| December 31, 2022 | 3.886 |
| September 30, 2022 | 2.454 |
| June 30, 2022 | 1.527 |
| March 31, 2022 | 1.062 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.8699 |
| September 30, 2021 | 0.2048 |
| June 30, 2021 | 0.1851 |
| March 31, 2021 | 0.831 |
| December 31, 2020 | -1.836 |
| September 30, 2020 | 3.788 |
| June 30, 2020 | 2.125 |
| March 31, 2020 | 1.470 |
| December 31, 2019 | 1.151 |
| September 30, 2019 | 5.331 |
| June 30, 2019 | 2.192 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-13.62
Minimum
Jun 2023
20.58
Maximum
Sep 2024
1.856
Average
1.311
Median
Debt to Equity Ratio Benchmarks
| Insulet Corp | 1.251 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
| Xtant Medical Holdings Inc | 0.7605 |
| Myomo Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 229.61M |
| Total Liabilities (Quarterly) | 223.72M |
| Shareholders Equity (Quarterly) | 5.89M |
| Current Ratio | 2.472 |
| Net Debt Paydown Yield | -0.51% |